BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2179792)

  • 21. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Micronized progesterone and its impact on the endometrium and breast vs. progestogens.
    Gompel A
    Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex steroids and cancer.
    Gambrell RD
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
    Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How progestins prevent endometrial cancer.
    Siddle NC
    Rev Fr Gynecol Obstet; 1985 Mar; 80(4):219-21. PubMed ID: 3992123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cancer risk under hormone therapy].
    Lauritzen C
    Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low dose hormone replacement therapy: clinical efficacy.
    Mattsson LA; Sporrong T
    Minerva Ginecol; 2003 Jun; 55(3):201-7. PubMed ID: 14581865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HRT dosing regimens: continuous versus cyclic-pros and cons.
    Shoupe D
    Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of progestogens in postmenopausal women.
    Gambrell RD
    Int J Fertil; 1989; 34(5):315-21. PubMed ID: 2571591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contraception for the perimenopausal patient.
    Upton GV
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Estrogens, progestins and cancer of the endometrium].
    Laffargue F; Daures JP
    Rev Prat; 1993 Dec; 43(20):2603-9. PubMed ID: 8146558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of estrogen/progestogen receptors in the endometrium.
    Casper RF
    Int J Fertil Menopausal Stud; 1996; 41(1):16-21. PubMed ID: 8673152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.